{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:01:08Z","timestamp":1772640068147,"version":"3.50.1"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Portuguese Foundation for Science and Technology (FCT)"},{"DOI":"10.13039\/501100000902","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000902","id-type":"DOI","asserted-by":"publisher"}]},{"name":"QREN"},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002339","name":"COMPETE","doi-asserted-by":"publisher","award":["PEst-C\/QUI\/UI0062\/2013"],"award-info":[{"award-number":["PEst-C\/QUI\/UI0062\/2013"]}],"id":[{"id":"10.13039\/501100002339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002339","name":"COMPETE","doi-asserted-by":"publisher","award":["PTDC\/DES\/114122\/2009"],"award-info":[{"award-number":["PTDC\/DES\/114122\/2009"]}],"id":[{"id":"10.13039\/501100002339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002339","name":"COMPETE","doi-asserted-by":"publisher","award":["FCOMP-01-0124-FEDER-014707"],"award-info":[{"award-number":["FCOMP-01-0124-FEDER-014707"]}],"id":[{"id":"10.13039\/501100002339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.cca.2014.06.022","type":"journal-article","created":{"date-parts":[[2014,6,28]],"date-time":"2014-06-28T07:01:33Z","timestamp":1403938893000},"page":"323-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Biomarkers for cardiac cachexia: Reality or utopia"],"prefix":"10.1016","volume":"436","author":[{"given":"Telma","family":"Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3636-5805","authenticated-orcid":false,"given":"Rui","family":"Vitorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Amado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Alberto","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2014.06.022_bb0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijcard.2012.10.019","article-title":"Liver metabolism in cardiac cachexia","volume":"162","author":"Springer","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clinbiochem.2013.10.025","article-title":"Recent insights on the molecular mechanisms and therapeutic approaches for cardiac cachexia","volume":"47","author":"Martins","year":"2014","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2014.06.022_bb0015","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/hrt.2002.007005","article-title":"Inflammatory mediators in chronic heart failure: an overview","volume":"90","author":"Anker","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.cca.2014.06.022_bb0020","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.cardiores.2006.08.018","article-title":"Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure","volume":"73","author":"von Haehling","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cca.2014.06.022_bb0025","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.biocel.2005.04.017","article-title":"Insulin-like growth factor-1 and muscle wasting in chronic heart failure","volume":"37","author":"Schulze","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cca.2014.06.022_bb0030","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.biocel.2005.03.013","article-title":"Muscle wasting in cardiac cachexia","volume":"37","author":"Strassburg","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cca.2014.06.022_bb0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF02696650","article-title":"Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches","volume":"2","author":"Akashi","year":"2005","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.cca.2014.06.022_bb0040","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.nurpra.2011.04.018","article-title":"Cardiac cachexia","volume":"7","author":"Cavey","year":"2011","journal-title":"J Nurse Pract"},{"key":"10.1016\/j.cca.2014.06.022_bb0045","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr"},{"key":"10.1016\/j.cca.2014.06.022_bb0050","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1378\/chest.115.3.836","article-title":"Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation","volume":"115","author":"Anker","year":"1999","journal-title":"CHEST J"},{"key":"10.1016\/j.cca.2014.06.022_bb0055","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(03)12892-9","article-title":"Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study","volume":"361","author":"Anker","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2014.06.022_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0167-5273(02)00239-5","article-title":"Neurohormonal factors in the development of catabolic\/anabolic imbalance and cachexia","volume":"85","author":"Brink","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0065","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pharmthera.2008.09.009","article-title":"Cardiac cachexia: a systematic overview","volume":"121","author":"von Haehling","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cca.2014.06.022_bb0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/SPC.0b013e32833237f1","article-title":"The pathophysiology of cardiac cachexia","volume":"3","author":"Freeman","year":"2009","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.cca.2014.06.022_bb0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0167-5273(02)00241-3","article-title":"Regulation of lipolysis: natriuretic peptides and the development of cachexia","volume":"85","author":"Kalra","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/pr0502525","article-title":"Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability","volume":"5","author":"Thongboonkerd","year":"2005","journal-title":"J Proteome Res"},{"key":"10.1016\/j.cca.2014.06.022_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jjcc.2011.11.001","article-title":"Biochemical markers in heart failure","volume":"59","author":"Sato","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2005.03.003","article-title":"Neurohormonal activation in congestive heart failure and the role of vasopressin","volume":"95","author":"Chatterjee","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0095","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0008-6363(01)00297-8","article-title":"Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin","volume":"51","author":"Kalra","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cca.2014.06.022_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0167-5273(02)00233-4","article-title":"The syndrome of cardiac cachexia","volume":"85","author":"Anker","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0105","first-page":"191","article-title":"Cardiac cachexia: pathophysiology and clinical implications","volume":"13","author":"Steinborn","year":"2003","journal-title":"Basic Appl Myol"},{"key":"10.1016\/j.cca.2014.06.022_bb0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1152\/jappl.1998.85.1.181","article-title":"Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue","volume":"85","author":"Millet","year":"1998","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.metabol.2011.05.011","article-title":"Serum adipokine zinc alpha2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers","volume":"61","author":"Tedeschi","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2014.06.022_bb0120","doi-asserted-by":"crossref","first-page":"D3","DOI":"10.1016\/S1520-765X(02)90154-9","article-title":"Neurohormonal modulation in chronic heart failure","volume":"4","author":"Ferrara","year":"2002","journal-title":"Eur. Heart J. Suppl"},{"key":"10.1016\/j.cca.2014.06.022_bb0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MAJ.0b013e318222e620","article-title":"Angiotensin II, oxidative stress and skeletal muscle wasting","volume":"342","author":"Sukhanov","year":"2011","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cca.2014.06.022_bb0130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/01.mco.0000222103.29009.70","article-title":"Angiotensin II as candidate of cardiac cachexia","volume":"9","author":"Delafontaine","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.cca.2014.06.022_bb0135","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.biocel.2013.05.035","article-title":"Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia","volume":"45","author":"Yoshida","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cca.2014.06.022_bb0140","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1161\/hc4201.097836","article-title":"Elevated circulating level of ghrelin in cachexia associated with chronic heart failure","volume":"104","author":"Nagaya","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2014.06.022_bb0145","doi-asserted-by":"crossref","first-page":"e30276","DOI":"10.1371\/journal.pone.0030276","article-title":"Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy","volume":"7","author":"Rezk","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2014.06.022_bb0150","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1172\/JCI118698","article-title":"Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism","volume":"97","author":"Brink","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2014.06.022_bb0155","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/HYPERTENSIONAHA.111.174839","article-title":"Angiotensin II upregulates protein phosphatase 2C\u03b1 and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting","volume":"58","author":"Tabony","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2014.06.022_bb0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/sj.bjc.6602725","article-title":"Angiotensin II directly induces muscle protein catabolism through the ubiquitin\u2013proteasome proteolytic pathway and may play a role in cancer cachexia","volume":"93","author":"Sanders","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cca.2014.06.022_bb0165","doi-asserted-by":"crossref","DOI":"10.1007\/s13539-014-0133-2","article-title":"1-Sarcosine-angiotensin II infusion effects on food intake, weight loss, energy expenditure, and skeletal muscle UCP3 gene expression in a rat model","author":"Cichello","year":"2014","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.cca.2014.06.022_bb0170","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0735-1097(00)01156-6","article-title":"Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting","volume":"37","author":"Dao","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0175","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2007.09.021","article-title":"Natriuretic peptides","volume":"50","author":"Daniels","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0180","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/paa.1999.111.5.406","article-title":"The natriuretic peptides in heart failure: diagnostic and therapeutic potentials","volume":"111","author":"Chen","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"key":"10.1016\/j.cca.2014.06.022_bb0185","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0735-1097(97)00452-X","article-title":"Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension","volume":"31","author":"Nagaya","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0190","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0002-8703(98)70054-7","article-title":"Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease","volume":"135","author":"Stein","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.cca.2014.06.022_bb0195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","article-title":"The role of natriuretic peptides in cardioprotection","volume":"69","author":"Nishikimi","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cca.2014.06.022_bb0200","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijcard.2008.11.146","article-title":"The relationship between tumor necrosis factor-\u03b1, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure","volume":"141","author":"Vaz P\u00e9rez","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0205","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.metabol.2013.09.017","article-title":"Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study","volume":"63","author":"Christensen","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2014.06.022_bb0210","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1096\/fj.14.10.1345","article-title":"Natriuretic peptides: a new lipolytic pathway in human adipocytes","volume":"14","author":"Sengen\u00e8s","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.cca.2014.06.022_bb0215","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.jacc.2009.02.037","article-title":"A new role for the natriuretic peptides: metabolic regulators of the adipocyte","volume":"53","author":"Costello-Boerrigter","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0220","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.CIR.96.2.526","article-title":"Hormonal changes and catabolic\/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia","volume":"96","author":"Anker","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2014.06.022_bb0225","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehm033","article-title":"Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide","volume":"28","author":"McEntegart","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2014.06.022_bb0230","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/euhj.1998.1446","article-title":"Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure","volume":"20","author":"Anker","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2014.06.022_bb0235","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1479-666X(06)80004-1","article-title":"The molecular mechanisms of skeletal muscle wasting: implications for therapy","volume":"4","author":"Skipworth","year":"2006","journal-title":"Surgeon"},{"key":"10.1016\/j.cca.2014.06.022_bb0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/110264802753704064","article-title":"Imbalance of catabolic and anabolic pathways in chronic heart failure: implications for the treatment of cardiac cachexia","volume":"46","author":"Anker","year":"2002","journal-title":"Scand J Nutr"},{"key":"10.1016\/j.cca.2014.06.022_bb0245","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1527-5299.2002.00724.x","article-title":"Immune and neurohormonal pathways in chronic heart failure","volume":"8","author":"Sharma","year":"2002","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.cca.2014.06.022_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0606","article-title":"Mechanisms of glucocorticoid-induced myopathy","volume":"197","author":"Schakman","year":"2008","journal-title":"J Endocrinol"},{"key":"10.1016\/j.cca.2014.06.022_bb0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13539-012-0085-3","article-title":"Effect of ghrelin and its analogues, BIM-28131 and BIM-28125, on the expression of myostatin in a rat heart failure model","volume":"4","author":"Lenk","year":"2013","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.cca.2014.06.022_bb0260","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12020-012-9836-3","article-title":"Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status","volume":"43","author":"Christensen","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.cca.2014.06.022_bb0265","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13539-011-0043-5","article-title":"Growth hormone, insulin-like growth factor 1, and insulin signaling\u2014a pharmacological target in body wasting and cachexia","volume":"2","author":"Trobec","year":"2011","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.cca.2014.06.022_bb0270","doi-asserted-by":"crossref","first-page":"E899","DOI":"10.1152\/ajpendo.00024.2006","article-title":"GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus","volume":"291","author":"J\u00f8rgensen","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.cca.2014.06.022_bb0275","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1172\/JCI10994","article-title":"TNF-\u03b1 downregulates murine hepatic growth hormone receptor expression by inhibiting Sp1 and Sp3 binding","volume":"107","author":"Denson","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2014.06.022_bb0280","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1074248411402078","article-title":"The potential effects of IGF-1 and GH on patients with chronic heart failure","volume":"17","author":"Perkel","year":"2012","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.cca.2014.06.022_bb0285","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0735-1097(97)00185-X","article-title":"Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure","volume":"30","author":"Swan","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1467-789X.2006.00270.x","article-title":"The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review","volume":"8","author":"Klok","year":"2007","journal-title":"Obes Rev"},{"key":"10.1016\/j.cca.2014.06.022_bb0295","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","article-title":"Adipose tissue, adipokines, and inflammation","volume":"115","author":"Fantuzzi","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cca.2014.06.022_bb0300","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1095-6433(00)00159-8","article-title":"Leptin: an essential regulator of lipid metabolism","volume":"125","author":"Reidy","year":"2000","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2005.05.019","article-title":"Leptin as a new diagnostic tool in chronic heart failure","volume":"362","author":"Schulze","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2014.06.022_bb0310","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1530\/eje.0.1450727","article-title":"Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia","volume":"145","author":"Doehner","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cca.2014.06.022_bb0315","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1388-9842(02)00177-0","article-title":"Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure","volume":"5","author":"Schulze","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cca.2014.06.022_bb0320","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0167-5273(00)00397-1","article-title":"Leptin serum levels in cachectic heart failure patients: relationship with tumor necrosis factor-\u03b1 system","volume":"76","author":"Filippatos","year":"2000","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0325","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/hrt.82.3.352","article-title":"Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure","volume":"82","author":"Murdoch","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.cca.2014.06.022_bb0330","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1096\/fj.03-0641rev","article-title":"Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ","volume":"18","author":"Inui","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.cca.2014.06.022_bb0335","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13539-010-0011-5","article-title":"Ghrelin for cachexia","volume":"1","author":"Akamizu","year":"2010","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.cca.2014.06.022_bb0340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0167-0115(03)00117-4","article-title":"Ghrelin, a novel growth hormone-releasing peptide, in the treatment of chronic heart failure","volume":"114","author":"Nagaya","year":"2003","journal-title":"Regul Pept"},{"key":"10.1016\/j.cca.2014.06.022_bb0345","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.regpep.2004.08.007","article-title":"Ghrelin: a gastric peptide that regulates food intake and energy homeostasis","volume":"126","author":"Ueno","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.cca.2014.06.022_bb0350","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/01.sla.0000118561.54919.61","article-title":"Ghrelin: integrative neuroendocrine peptide in health and disease","volume":"239","author":"Wu","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.cca.2014.06.022_bb0355","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.bbrc.2003.09.045","article-title":"C-terminal pro-ghrelin peptides are present in the human circulation","volume":"310","author":"Pemberton","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cca.2014.06.022_bb0360","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/13547500903560065","article-title":"Rapid emergence of multimarker strategies in laboratory medicine","volume":"15","author":"Gruson","year":"2010","journal-title":"Biomarkers"},{"key":"10.1016\/j.cca.2014.06.022_bb0365","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature06802","article-title":"The search for new cardiovascular biomarkers","volume":"451","author":"Gerszten","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cca.2014.06.022_bb0370","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phrs.2011.03.006","article-title":"Multimarker approach for heart failure management: perspectives and limitations","volume":"64","author":"Giannessi","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cca.2014.06.022_bb0375","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cca.2014.06.022_bb0380","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10741-009-9144-z","article-title":"Multi-marker strategies in heart failure: clinical and statistical approaches","volume":"15","author":"Allen","year":"2010","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cca.2014.06.022_bb0385","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s11886-010-0109-6","article-title":"Use of multiple biomarkers in heart failure","volume":"12","author":"Allen","year":"2010","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.cca.2014.06.022_bb0390","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002254","article-title":"Assessment of a multimarker strategy for prediction of mortality in older heart failure patients: a cohort study","volume":"3","author":"Bjurman","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.cca.2014.06.022_bb0395","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mayocp.2012.09.016","article-title":"Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment","volume":"88","author":"Lupon","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cca.2014.06.022_bb0400","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.ahj.2005.01.049","article-title":"Relationship between anemia, cardiac troponin I, and B-type natriuretic peptide levels and mortality in patients with advanced heart failure","volume":"150","author":"Ralli","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.cca.2014.06.022_bb0405","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.jacc.2006.06.056","article-title":"Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction?","volume":"48","author":"van Kimmenade","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0410","first-page":"A66","article-title":"Do biomarkers add prognostic information to routine measures of the severity of heart failure?","volume":"47","author":"Anand","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0415","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cardfail.2012.11.002","article-title":"Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure","volume":"19","author":"Alehagen","year":"2013","journal-title":"J Card Fail"},{"key":"10.1016\/j.cca.2014.06.022_bb0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-012-0086-2","article-title":"Serological muscle loss biomarkers: an overview of current concepts and future possibilities","volume":"4","author":"Nedergaard","year":"2013","journal-title":"J Cachex Sarcopenia Muscle"},{"key":"10.1016\/j.cca.2014.06.022_bb0425","first-page":"1834","article-title":"The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity","volume":"85","author":"Moriyama","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2014.06.022_bb0430","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2007.08.115","article-title":"Dehydroepiandrosterone levels vary according as heart failure condition in patients with idiopathic dilated cardiomyopathy","volume":"125","author":"Kawano","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0435","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0735-1097(01)01385-7","article-title":"Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone","volume":"38","author":"Anker","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0440","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000353291","article-title":"Serum adiponectin, anemia and left ventricular dimensions in patients with cardiac cachexia","volume":"126","author":"Bozcali","year":"2013","journal-title":"Cardiology"},{"key":"10.1016\/j.cca.2014.06.022_bb0445","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/eurjhf\/hfp046","article-title":"Adiponectin is increased in cardiac cachexia irrespective of body mass index","volume":"11","author":"Araujo","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cca.2014.06.022_bb0450","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0002-9149(98)00872-8","article-title":"Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"83","author":"Aukrust","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cca.2014.06.022_bb0460","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1067\/mhj.2001.114367","article-title":"Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance","volume":"141","author":"Doehner","year":"2001","journal-title":"Am Heart J"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114002800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114002800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T20:48:09Z","timestamp":1565556489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898114002800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":91,"alternative-id":["S0009898114002800"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2014.06.022","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers for cardiac cachexia: Reality or utopia","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2014.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}